Skip to main content

Table 5 Cardiac findings according to CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

 

MD

Normal CMR

Abnormal CMR

p value

N = 63

N = 14

N = 49

LV-EDVi, ml/m2

85 ± 30

72 ± 19

88 ± 32

0.08

LV-ESVi, ml/m2

41 ± 21

24 ± 7

46 ± 21

<0.0001

LV-mass, g/m2

60 ± 16

52 ± 11

62 ± 17

0.037

LV-EF, %

53 ± 12

67 ± 6

50 ± 11

<0.0001

RV-EF, %

53 ± 9

58 ± 7

52 ± 9

0.023

LV-EF <55 %, n (%)

29 (46)

0 (0)

29 (59)

NA

RV-EF <45 %, n (%)

10 (16)

0 (0)

10 (20)

NA

LGE presence, n (%)

48 (76)

0 (0)

48 (98)

NA

LGE extent, %

7 (1–17)

-

10 (4–24)

NA

  1. Bold text indicates a significant p-value of <0.05